Promising Results Using New Drug to Reverse Scleroderma

In a lab meeting of Dr. Eduardo Marban of Cedars Sinai Medical Center in Los Angeles, California Dr. Michael Jones presented results obtained in two mouse models and one human macrophage study showing the new experimental DNA drug TY1 reversed scleroderma.